Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.42 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10324974 | 0.80 | ALOX5 (0.48) | GPR3BRDTMAPTMEN1KMT2A | |
| SCHEMBL16553298 | 0.80 | GPR3 (0.59) | GPR3BRDTMAPTMEN1POLB | |
| SCHEMBL30550557 | 0.80 | GPR3 (0.59) | GPR3BRDTMAPTMEN1POLB | |
| SCHEMBL1369327 | 0.78 | ALDH1A1 (0.38) | HPGDALDH1A1CYP1A2 | |
| SCHEMBL16670320 | 0.78 | GPR3 (0.56) | GPR3BRDTMAPTMEN1POLB | |
| SCHEMBL15987453 | 0.76 | GPR3 (0.38) | GPR3BRDTMAPTMEN1POLB | |
| SCHEMBL21001589 | 0.75 | GPR3 (0.43) | GPR3BRDTMAPTMEN1POLB | |
| SCHEMBL20696037 | 0.74 | GPR3 (0.52) | GPR3BRDTMAPTMEN1POLB | |
| SCHEMBL30302800 | 0.74 | GPR3 (0.52) | GPR3BRDTMAPTMEN1POLB | |
| SCHEMBL28961054 | 0.74 | GPR3 (0.52) | GPR3BRDTMAPTMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820304-A | Organic material composition and application thereof | 宁波卢米蓝新材料有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-116671278-A | Organic light emitting device | 株式会社LG化学 | 2023-08-29 | — | — | CN | claimed |
| CN-116396746-A | Organic electroluminescent compounds and use thereof | 宁波卢米蓝新材料有限公司 | 2023-07-07 | — | — | CN | claimed |
| US-20180033965-A1 | NOVEL DIAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2018-02-01 | — | — | US | claimed |
| EP-2772483-B1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | TOSOH CORP (JP) | 2017-03-29 | — | — | EP | claimed |
| US-9172045-B2 | 4-aminocarbazole compound and use thereof | TOSOH CORPORATION (JP) | 2015-10-27 | — | — | US | claimed |
| US-20140296519-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE THEREOF | TOSOH CORPORATION (JP) | 2014-10-02 | — | — | US | claimed |
| EP-2772483-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | Tosoh Corporation (JP) | 2014-09-03 | — | — | EP | claimed |
| CN-117820304-A | Organic material composition and application thereof | 宁波卢米蓝新材料有限公司 | 2024-04-05 | — | — | CN | disclosed |
| WO-2024057844-A1 | ORGANIC LIGHT EMITTING DEVICE, AND DESIGN METHOD AND PROGRAM THEREOF | 株式会社Kyulux | 2024-03-21 | — | — | WO | disclosed |
| CN-110551086-B | Organic compound, organic light emitting diode and organic light emitting display device including the same | 乐金显示有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-116671278-A | Organic light emitting device | 株式会社LG化学 | 2023-08-29 | — | — | CN | disclosed |
| CN-116396746-A | Organic electroluminescent compounds and use thereof | 宁波卢米蓝新材料有限公司 | 2023-07-07 | — | — | CN | disclosed |
| WO-2023101004-A1 | OLEFIN RESIN, METHOD FOR MANUFACTURING SAME, AND APPLICATION FOR SAME | 三井化学株式会社 | 2023-06-08 | — | — | WO | disclosed |
| WO-2013062043-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | 東ソー株式会社 (JP) | 2013-05-02 | — | — | WO | disclosed |
| EP-2564441-A1 | ORGANIC LIGHT-EMITTING DEVICE | Canon Kabushiki Kaisha (JP) | 2013-03-06 | — | — | EP | disclosed |
| US-20130037791-A1 | ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20120273766-A1 | AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-11-01 | — | — | US | disclosed |
| US-20120181524-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
| WO-2011136156-A1 | ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2011-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180033965-A1 | NOVEL DIAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | OR10J3, AOC1, SAT1 | GPR3 57/4885BRDT 795/4885MAPT 2859/4885 |
| US-20120181524-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | AOC3, NPR3, NR0B1 | GPR3 281/4885BRDT 2719/4885MAPT 2755/4885 |
| US-20120273766-A1 | AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | DDC, ODC1, TYR | GPR3 4215/4885BRDT 1691/4885MAPT 2447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.